CS
ACLX

Candriam SCA’s Arcellx ACLX Stock Holding History

Candriam SCA’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-96,420
Closed -$6.29M – 693
2025
Q4 		$6.29M Buy
+96,420
New +$7.69M 0.03% 346
2025
Q2 		– Sell
-70,538
Closed -$4.63M – 676
2025
Q1 		$4.63M Sell
70,538
-124,458
-64% -$8.43M 0.03% 342
2024
Q4 		$15M Sell
194,996
-45,367
-19% -$3.92M 0.09% 210
2024
Q3 		$20.1M Buy
240,363
+23,355
+11% +$1.56M 0.12% 177
2024
Q2 		$12M Sell
217,008
-3,000
-1% -$163K 0.07% 234
2024
Q1 		$15.3M Sell
220,008
-62,005
-22% -$3.93M 0.1% 201
2023
Q4 		$15.7M Sell
282,013
-116,007
-29% -$5.23M 0.11% 191
2023
Q3 		$14.3M Hold
398,020
– – 0.1% 187
2023
Q2 		$12.6M Sell
398,020
-49,134
-11% -$1.88M 0.09% 217
2023
Q1 		$12.7M Buy
447,154
+25,000
+6% +$758K 0.09% 224
2022
Q4 		$13.1M Buy
422,154
+388,931
+1,171% +$8.92M 0.09% 221
2022
Q3 		$624K Buy
+33,223
New +$636K ﹤0.01% 793

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Candriam SCA's ACLX Position: Q1 2026 in Review

Candriam SCA sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 96,420 shares — an estimated $6.29M sold.

Candriam SCA first reported a position in ACLX in Q3 2022 and held it in 12 quarters. The position peaked at $20.1M in Q3 2024. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Candriam SCA reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
  • Candriam SCA sold 96,420 Arcellx shares in Q1 2026, an estimated $6.29M.
  • Candriam SCA first reported a position in Arcellx in Q3 2022 and held it in 12 quarters.
  • Candriam SCA's Arcellx position peaked at $20.1M in Q3 2024.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.